🇨🇿 Czech Republic · TED contract award · ocds-ted-463335-2025

Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek CAR-T terapie - ABECMA

Kč334M Awarded value

2025-07-16 Award date

1 Sectors

Contract description

Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek CAR-T terapie - ABECMA

Connected to.

Buying agency

Fakultní nemocnice Ostrava

Winning supplier

Bristol-Myers Squibb spol. s r.o.

Sectors

professional-services-consulting

Country

🔒 Premium

Full award context

Every related award by this supplier to this agency, line-item breakdown, sub-sector tags, and the complete bid history — plus CSV / API export.

More awards won by Bristol-Myers Squibb spol. s r.o.

Czechia – Antineoplastic and immunomodulating agents – DKč1,025,801,725

Czechia – Antineoplastic agents – LP s obsahem nivolumabKč495,811,617

Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYKč417,507,440

Czechia – Antineoplastic agents – Léčivé přípravky s obsKč345,966,000

Czechia – Antineoplastic and immunomodulating agents – LKč345,966,000

Czechia – Medical preparations excluding dental consumabKč340,466,675

Other contracts from Fakultní nemocnice Ostrava

Czechia – Antineoplastic and immunomodulating agents – LKč345,966,000

Czechia – Pharmaceutical products – DODÁVKY LÉČIVÝCH PŘÍKč319,230,508

Czechia – Artificial parts of the heart – Systém pro katKč312,417,389

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →